Target intelligence / Profile preview

3-phosphoinositide dependent protein kinase 2, pseudogene (PDPK2P)

Target
PDPK2P
Molecular classification
Pseudogene, Long noncoding RNA (lncRNA)
01

Overview

PDPK2P (3-phosphoinositide dependent protein kinase 2, pseudogene) is a non-protein coding gene/Pseudogene that gives rise to a long noncoding RNA, lncRNA-PDPK2P, which is highly homologous to the functional kinase PDK1 but does not encode an active enzyme[2][1]. The transcript of PDPK2P acts as a competitive endogenous RNA, regulating cell proliferation, apoptosis, migration, and invasion, particularly in hepatocellular carcinoma, by interacting with PDK1 and modulating the PDK1/AKT/caspase signaling cascade[1]. This pseudogene is not a conventional protein target and is not referenced in major drug-interaction databases. Its altered expression is clinically associated with tumor progression and poor prognosis, and it is of interest mainly as a disease biomarker or possible regulatory mechanism in cancer biology[1].

Other names
Putative 3-phosphoinositide-dependent protein kinase 2PDPK23-phosphoinositide-dependent protein kinase 2 pseudogene3-phosphoinositide dependent protein kinase-1 pseudogeneEC 2.7.11.1
02

Mechanism of action

None directly; lncRNA-PDPK2P regulates PDK1 function via RNA-RNA interaction and competitive endogenous RNA (ceRNA) mechanisms affecting the PDK1/AKT/caspase pathway

03

Biological functions

Intracellular signal transduction (as regulatory RNA, not as an enzyme)Regulation of cell proliferationRegulation of apoptosisRegulation of migration and invasion (in cancer cells)
04

Disease associations

Cancer (specifically implicated in hepatocellular carcinoma progression and poor prognosis)
05

Safety considerations

None established for direct targeting; therapeutic strategies would have to consider off-target gene regulation effects if targeting the RNA
06

Biomarkers

lncRNA-PDPK2P is suggested as a potential biomarker for hepatocellular carcinoma diagnosis, prognosis, and possibly patient selection

Beyond the preview

Go deeper on 3-phosphoinositide dependent protein kinase 2, pseudogene (PDPK2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-phosphoinositide dependent protein kinase 2, pseudogene (PDPK2P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call